MSH2 and cancer: Regarding the other cancer-associated genes, the cancer panel and exome detected six incidental variants in five patients (10%), in four different genes: one pathogenic and one likely pathogenic variant in CHEK2, two pathogenic variants in MUTYH, and one each in MSH2 and WRN (Table 5).